Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had surgery to remove early-stage breast cancer (Stage I, II, or IIIa), whether the cancer was hormone receptor-positive or hormone receptor-negative
- People with hormone receptor-positive breast cancer who are currently on hormone-blocking (endocrine) therapy, including those also taking certain targeted therapies alongside that hormone-blocking treatment in an after-surgery (adjuvant) setting
- People with hormone receptor-negative breast cancer who are in the monitoring/follow-up phase after treatment
- Women aged 18 or older
- People who are able and willing to provide written consent before any study activities begin
Who may not be able to join:
- People whose breast cancer has spread to other parts of the body (advanced or metastatic breast cancer)
- People with early-stage breast cancer who are currently receiving chemotherapy or anti-HER2 treatments, either before or after surgery
- People who are currently being actively treated for a second, separate cancer — though people with a type of common skin cancer called basal cell carcinoma, or very early-stage non-invasive tumours (in situ), may still be eligible (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mattia Garutti, MD, IRCCS-Centro di Riferimento Oncologico (CRO), Aviano (PN)
Phone: 0434 659092
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of nutritional knowledge in patients with surgically removed early breast cancer; Evaluation of dietary habits in patients with surgically removed early breast cancer; Evaluation of physical activity in patients with surgically removed early breast cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.